Oncology CT

Dropping National Lung Cancer Screening radiation dose by two-thirds can yield images of diagnostic quality of solid lung nodules.

Men in this patient group are less likely to have a PET scan with the radiotracer that performs the best.

PET/MRI vs. PET/CT; Abdominal CT and COVID-19; Chest MRI vs Chest CT; Expert Interpretations of Endometriosis; and Delayed Breast Cancer Treatments for African American Women

CEUS is a safer, less expensive option for diagnosing focal liver disease.

Azurion Lung Edition is supports precision diagnosis and minimally invasive therapy in one room.

Treatment does not significantly change three-year disease-free survival rates.

States with expanded coverage saw an increase in cancer diagnosis for covered adults, as well as the overall population.

PET/MRI detects more lesions with less radiation, making it a great option for pediatric patients.

Rethinking CMR during COVID-19; Abdominal Imaging and COVID-19; Mental Health Impacts of COVID-19; African American and Lung Cancer Screening; Plus, African American Women and Disadvantages in Breast Cancer Screening

Low-dose CT scans could catch more cancers if the lung cancer screening threshold were dropped to a history of 20-pack-years.

CT and heart attack prediction; lagging outpatient imaging volume recovery; equivalent thoracic MRI performance with COVID-19 pneumonia; and CT colonography during COVID-19

Researchers identify 18F-PMSA-1007 as an equally effective radiopharmaceutical for detecting prostate cancer.

21-expert panel outlined 12 recommendations for when you can delay lung cancer screenings and lung nodule evaluations.

Molecular imaging technique performs better with detection, staging, and determining treatment plans.

Decade-long trial shows frequent CT screening reduces high-risk smokers’ likelihood of dying from lung cancer.

The imaging process provides the most time-efficient sequence with the highest lesion detection rate and conspicuity.

Thirty-two men participated in the retrospective study.

Coverage for prostate MRIs results in challenges for patients and referring physicians seeking to obtain ready access.

Despite recommendations, shared decision-making for lung cancer screening in practice may be far from what is intended by guidelines.

Despite undergoing more imaging outside the VA system, men with low-risk prostate cancer don’t show an improvement in care quality.

Thorough prescreening evaluation is one critical element for a safe and successful lung cancer screening program.

PSA-density does not appear to significantly improve its diagnostic performance.

May contribute to knowledge gap inhibiting patients from improving their health literacy.

A structured template for PI-RADS may increase the diagnostic performance of prostate MRI for clinically significant prostate cancer.

The Bach model, PLCOM2012, LCRAT, and LCDRAT most accurately predict risk and performed best in selecting ever-smokers for screening.